Wilfactin

Wilfactin is a human von Willebrand factor concentrate used to manage bleeding disorders like von Willebrand disease. This intravenous therapy supports blood clotting by replacing missing or deficient proteins. Suitable for patients requiring factor replacement during procedures or acute bleeding events.

Wilfactin is prescribed to prevent or control bleeding in individuals with von Willebrand disease, a condition where blood does not clot properly due to a deficiency in von Willebrand factor. It may be used before surgeries or dental procedures to reduce bleeding risk. The medication works by temporarily restoring normal clotting function in the bloodstream.

When administered, Wilfactin helps restore the body’s natural clotting ability by supplying the missing von Willebrand factor. Patients may experience improved bleeding control and reduced bruising or prolonged bleeding episodes. The effects are temporary and depend on individual response and dosing.

Wilfactin should be handled with care and used only under medical supervision. Patients with known allergies to human blood products should inform their healthcare provider before use. Proper storage and handling are essential to maintain product integrity and effectiveness.

Wilfactin may interact with medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Patients should disclose all current medications to their healthcare provider to avoid potential interactions. No specific food or alcohol interactions have been widely reported with this therapy.